Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Sean Godbout is Chief Accounting Officer at Biogen. OQRO lists 17 transactions filed with the SEC under this name, the latest on Oct 5, 2026, each linked to the official Form 4.
Chief Accounting Officer
Disclosures on record
17
Companies involved
1
As of the latest filing on , Sean Godbout reported holding 1,459 shares of Biogen (BIIB), worth about $367K at the last close of $251 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Biogen BIIB | 1,459 | 1,459 direct | $251 | $367K | Oct 2, 2026 |
Is this Sean Godbout’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
BiogenBIIB
17 disclosures · Feb 2026 – Oct 2026
Oct 1, 2026985disclosed Oct 5
DetailsOfficial recordOct 2, 202627disclosed Oct 5
DetailsOfficial recordOct 2, 202627disclosed Oct 5
DetailsOfficial recordOct 2, 20268disclosed Oct 5
DetailsOfficial recordApr 1, 2026181disclosed Apr 3
DetailsOfficial recordApr 1, 2026181disclosed Apr 3
DetailsOfficial recordApr 1, 202654disclosed Apr 3
DetailsOfficial recordFeb 13, 20261,800disclosed Feb 18
DetailsOfficial recordFeb 6, 2026517disclosed Feb 10
DetailsOfficial recordFeb 6, 2026257disclosed Feb 10
DetailsOfficial recordFeb 6, 2026305disclosed Feb 10
DetailsOfficial recordFeb 6, 2026517disclosed Feb 10
DetailsOfficial recordFeb 6, 2026257disclosed Feb 10
DetailsOfficial recordFeb 6, 2026305disclosed Feb 10
DetailsOfficial recordFeb 6, 2026103disclosed Feb 10
DetailsOfficial recordFeb 6, 202676disclosed Feb 10
DetailsOfficial recordFeb 6, 2026180disclosed Feb 10
DetailsOfficial recordOn the latest SEC Form 4, dated Oct 2, 2026, Sean Godbout reported holding 1,459 shares of Biogen (BIIB). At the last close of $251 on Nov 18, 2026, that is about $367K. This is the stake disclosed in filings, not a net worth.
No public filing gives Sean Godbout's net worth. What SEC Form 4 shows is the stock stake: 1,459 shares of Biogen (BIIB), about $367K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.